Investment Analysts’ Upgrades for November 17th (ALAB, APOG, BALL, BXMT, CLAR, COCO, CRL, EXPD, EXPO, FTCI)

Investment Analysts’ upgrades for Monday, November 17th:

Astera Labs (NASDAQ:ALAB) was upgraded by analysts at Northland Securities from a market perform rating to an outperform rating. The firm currently has $175.00 target price on the stock.

Apogee Enterprises (NASDAQ:APOG) was upgraded by analysts at DA Davidson from a neutral rating to a buy rating. DA Davidson currently has $47.00 price target on the stock.

Ball (NYSE:BALL) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. The firm currently has $61.00 target price on the stock.

Blackstone Mortgage Trust (NYSE:BXMT) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating. The firm currently has $21.00 price target on the stock, up from their previous price target of $20.00.

Clarus (NASDAQ:CLAR) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Vita Coco (NASDAQ:COCO) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. The firm currently has $54.00 target price on the stock, up from their previous target price of $48.00.

Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Argus from a hold rating to a buy rating.

Expeditors International of Washington (NASDAQ:EXPD) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. UBS Group AG currently has $166.00 target price on the stock, up from their previous target price of $138.00.

Exponent (NASDAQ:EXPO) was upgraded by analysts at William Blair from a market perform rating to an outperform rating.

FTC Solar (NASDAQ:FTCI) was upgraded by analysts at Roth Capital from a neutral rating to a buy rating.

Guardian Pharmacy Services (NYSE:GRDN) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Coca Cola Femsa (NYSE:KOF) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

MYR Group (NASDAQ:MYRG) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Nomadar (NASDAQ:NOMA) was upgraded by analysts at Wall Street Zen to a hold rating.

Nucor (NYSE:NUE) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

O-I Glass (NYSE:OI) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. The firm currently has $17.00 target price on the stock, up from their previous target price of $14.00.

Petroleo Brasileiro S.A.- Petrobras (NYSE:PBR) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Philip Morris International (NYSE:PM) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Rubrik (NYSE:RBRK) was upgraded by analysts at Mizuho from a neutral rating to an outperform rating. They currently have $97.00 target price on the stock.

Regeneron Pharmaceuticals (NASDAQ:REGN) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Sylvamo (NYSE:SLVM) was upgraded by analysts at Bank of America Corporation from an underperform rating to a buy rating. Bank of America Corporation currently has $59.00 price target on the stock, up from their previous price target of $41.00.

Stellantis (NYSE:STLA) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

United Microelectronics (NYSE:UMC) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Block (NYSE:XYZ) was upgraded by analysts at Truist Financial Corporation from a sell rating to a hold rating.

Exzeo Group (NYSE:XZO) was upgraded by analysts at Wall Street Zen to a hold rating.

Yum! Brands (NYSE:YUM) was upgraded by analysts at TD Cowen from a hold rating to a buy rating. The firm currently has $173.00 target price on the stock, up from their previous target price of $162.00.

Receive News & Ratings for Astera Labs Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs Inc and related companies with MarketBeat.com's FREE daily email newsletter.